What is Deltex Medical Group plc (DTXMF)?

Deltex Medical Group plc (DTXMF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of DTXMF?

The current price of DTXMF is $0.10. Prices are updated in real time on Stocks360.

What is DTXMF's price-to-earnings (PE) ratio?

DTXMF's trailing twelve-month PE ratio is -78.80, based on current price and earnings per share data available on Stocks360.

What is DTXMF's market capitalization?

DTXMF's market capitalization is $180,577,488.00, placing it in the small-cap tier.

Deltex Medical Group plc (DTXMF)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.10

Market Cap

$180.58M

PE (TTM)

-78.80

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-2.06

Day Range

$0.00 – $0.10

52-wk Range

$0.00 – $0.10

Avg Volume

N/A

Volume

55.00K

Deltex Medical Group plc (DTXMF) is a publicly traded company in the Healthcare sector. Latest price: $0.10. Market cap $180.58M. Trailing PE -78.80. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.10 2026-08-04 · $0.10 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Deltex Medical Group plc

Deltex Medical Group plc, with its global presence encompassing the United Kingdom, the United States, Spain, and Canada, is dedicated to the development, marketing, and distribution of its TrueVue brand of esophageal Doppler hemodynamic monitoring systems. The company's innovative product lineup features: Esophageal Doppler Probes: These probes are engineered to accurately gauge a patient's central vascular blood flow and fluid status by continuously measuring real-time blood velocities within the descending aorta. Loops plots: This technology provides dynamic visualization of aortic blood flow velocity and aortic blood pressure, tracked meticulously with every single heartbeat. High Definition Impedance Cardiography: A non-invasive solution for monitoring cardiac function and fluid balance in conscious patients. PressureWave: An advanced algorithm that performs pulse pressure waveform analysis, particularly valuable during periods of patient instability or when the esophageal Doppler mode (ODM) is not available. Beyond monitoring devices, Deltex Medical also offers the Deltex Medical Esophageal Doppler Simulator. This tool allows clinicians to hone their skills in probe insertio…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-78.80×
P/S (TTM)	65.40×
P/B	83.94×
P/FCF (TTM)	-274.43×
EV / EBITDA	-230.53×
EV / Sales	66.27×
Earnings Yield	-1.34%
Free Cash Flow Yield	-0.36%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$136.24M
Revenue (TTM)	$2.06M
Net Income (TTM)	-$1.80M
Free Cash Flow (TTM)	-$490.00K
Net Debt	$1.77M
Working Capital	-$547.00K
Gross Margin	68.00%
Operating Margin	-77.14%
Net Margin	-87.40%
Return on Equity	-73.51%
Return on Invested Capital	-44.75%